Terms: = Prostate cancer AND IL7R, P16871, IL-7R-alpha, CDW127, CD127, ENSG00000168685, 3575
22 results:
1. Adverse health outcomes among rural prostate cancer survivors: A population-based study.
Huang D; Chang CE; Newman M; Deshmukh V; Snyder J; Date A; Galvao C; Lloyd S; Henry NL; O'Neil B; Hashibe M
Cancer Epidemiol; 2023 Oct; 86():102430. PubMed ID: 37473579
[TBL] [Abstract] [Full Text] [Related]
2. A population-based study of factors associated with systemic treatment in advanced prostate cancer decedents.
Leigh J; Qureshi D; Sucha E; Mahdavi R; Kushnir I; Lavallée LT; Bosse D; Webber C; Tanuseputro P; Ong M
Cancer Med; 2023 Mar; 12(5):5569-5579. PubMed ID: 36397730
[TBL] [Abstract] [Full Text] [Related]
3. Initial Findings from a High Genetic Risk prostate cancer Clinic.
Sessine MS; Das S; Park B; Salami SS; Kaffenberger SD; Kasputis A; Solorzano M; Luke M; Vince RA; Kaye DR; Borza T; Stoffel EM; Cobain E; Merajver SD; Jacobs MF; Milliron KJ; Caba L; van Neste L; Mondul AM; Morgan TM
Urology; 2021 Oct; 156():96-103. PubMed ID: 34280438
[TBL] [Abstract] [Full Text] [Related]
4. Thymoquinone inhibits IL-7-induced tumor progression and metastatic invasion in prostate cancer cells by attenuating matrix metalloproteinase activity and Akt/NF-κB signaling.
Alshyarba M; Otifi H; Al Fayi M; A Dera A; Rajagopalan P
Biotechnol Appl Biochem; 2021 Dec; 68(6):1403-1411. PubMed ID: 33128273
[TBL] [Abstract] [Full Text] [Related]
5. IL-23 and PSMA-targeted duo-CAR T cells in prostate cancer Eradication in a preclinical model.
Wang D; Shao Y; Zhang X; Lu G; Liu B
J Transl Med; 2020 Jan; 18(1):23. PubMed ID: 31937346
[TBL] [Abstract] [Full Text] [Related]
6. Vitamin D receptor gene polymorphisms and prostate cancer.
Braczkowski RS; Kwiatkowski R; Danikiewicz A; Górczyńska-Kosiorz S; Trautsolt W; Braczkowska B; Grzeszczak W
J Biol Regul Homeost Agents; 2018; 32(5):1245-1248. PubMed ID: 30334420
[TBL] [Abstract] [Full Text] [Related]
7. Male BRCA mutation carriers: clinical characteristics and cancer spectrum.
Ibrahim M; Yadav S; Ogunleye F; Zakalik D
BMC Cancer; 2018 Feb; 18(1):179. PubMed ID: 29433453
[TBL] [Abstract] [Full Text] [Related]
8. Inhibition of the hedgehog pathway in patients with basal-cell nevus syndrome: final results from the multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
Tang JY; Ally MS; Chanana AM; Mackay-Wiggan JM; Aszterbaum M; Lindgren JA; Ulerio G; Rezaee MR; Gildengorin G; Marji J; Clark C; Bickers DR; Epstein EH
Lancet Oncol; 2016 Dec; 17(12):1720-1731. PubMed ID: 27838224
[TBL] [Abstract] [Full Text] [Related]
9. IL-7/IL-7 receptor axis stimulates prostate cancer cell invasion and migration via AKT/NF-κB pathway.
Qu H; Zou Z; Pan Z; Zhang T; Deng N; Chen G; Wang Z
Int Immunopharmacol; 2016 Nov; 40():203-210. PubMed ID: 27611862
[TBL] [Abstract] [Full Text] [Related]
10. Multimodal treatment for high-risk prostate cancer with high-dose intensity-modulated radiation therapy preceded or not by radical prostatectomy, concurrent intensified-dose docetaxel and long-term androgen deprivation therapy: results of a prospective phase II trial.
Guttilla A; Bortolus R; Giannarini G; Ghadjar P; Zattoni F; Gnech M; Palumbo V; Valent F; Garbeglio A; Zattoni F
Radiat Oncol; 2014 Jan; 9():24. PubMed ID: 24423462
[TBL] [Abstract] [Full Text] [Related]
11. Analysis of circulating regulatory T cells (CD4+CD25+cd127-) after cryosurgery in prostate cancer.
Si TG; Wang JP; Guo Z
Asian J Androl; 2013 Jul; 15(4):461-5. PubMed ID: 23728588
[TBL] [Abstract] [Full Text] [Related]
12. Up-regulation of proliferative and migratory genes in regulatory T cells from patients with metastatic castration-resistant prostate cancer.
Huen NY; Pang AL; Tucker JA; Lee TL; Vergati M; Jochems C; Intrivici C; Cereda V; Chan WY; Rennert OM; Madan RA; Gulley JL; Schlom J; Tsang KY
Int J Cancer; 2013 Jul; 133(2):373-82. PubMed ID: 23319273
[TBL] [Abstract] [Full Text] [Related]
13. Aspirin but not ibuprofen use is associated with reduced risk of prostate cancer: a PLCO study.
Shebl FM; Sakoda LC; Black A; Koshiol J; Andriole GL; Grubb R; Church TR; Chia D; Zhou C; Chu LW; Huang WY; Peters U; Kirsh VA; Chatterjee N; Leitzmann MF; Hayes RB; Hsing AW
Br J Cancer; 2012 Jun; 107(1):207-14. PubMed ID: 22722313
[TBL] [Abstract] [Full Text] [Related]
14. Differential patterns of large tumor antigen-specific immune responsiveness in patients with BK polyomavirus-positive prostate cancer or benign prostatic hyperplasia.
Sais G; Wyler S; Hudolin T; Banzola I; Mengus C; Bubendorf L; Wild PJ; Hirsch HH; Sulser T; Spagnoli GC; Provenzano M
J Virol; 2012 Aug; 86(16):8461-71. PubMed ID: 22647697
[TBL] [Abstract] [Full Text] [Related]
15. Androgen deprivation boosts prostatic infiltration of cytotoxic and regulatory T lymphocytes and has no effect on disease-free survival in prostate cancer patients.
Sorrentino C; Musiani P; Pompa P; Cipollone G; Di Carlo E
Clin Cancer Res; 2011 Mar; 17(6):1571-81. PubMed ID: 21159885
[TBL] [Abstract] [Full Text] [Related]
16. Analysis of circulating regulatory T cells in patients with metastatic prostate cancer pre- versus post-vaccination.
Vergati M; Cereda V; Madan RA; Gulley JL; Huen NY; Rogers CJ; Hance KW; Arlen PM; Schlom J; Tsang KY
Cancer Immunol Immunother; 2011 Feb; 60(2):197-206. PubMed ID: 20976449
[TBL] [Abstract] [Full Text] [Related]
17. prostatectomy restores the maturation competence of blood dendritic cell precursors and reverses the abnormal expansion of regulatory T lymphocytes.
Brusa D; Carletto S; Cucchiarale G; Gontero P; Greco A; Simone M; Ferrando U; Tizzani A; Matera L
Prostate; 2011 Mar; 71(4):344-52. PubMed ID: 20812225
[TBL] [Abstract] [Full Text] [Related]
18. Pretreatment frequency of circulating IL-17+ CD4+ T-cells, but not Tregs, correlates with clinical response to whole-cell vaccination in prostate cancer patients.
Derhovanessian E; Adams V; Hähnel K; Groeger A; Pandha H; Ward S; Pawelec G
Int J Cancer; 2009 Sep; 125(6):1372-9. PubMed ID: 19533748
[TBL] [Abstract] [Full Text] [Related]
19. Effect of neoadjuvant epirubicin and total androgen blockade on complete pathological response in patients with clinical stage T3/T4 prostate cancer.
Francini G; Paolelli L; Francini E; Pascucci A; Manganelli A; Salvestrini F; Petrioli R
Eur J Surg Oncol; 2008 Feb; 34(2):216-21. PubMed ID: 17502132
[TBL] [Abstract] [Full Text] [Related]
20. Work and retirement after cancer diagnosis.
Bednarek HL; Bradley CJ
Res Nurs Health; 2005 Apr; 28(2):126-35. PubMed ID: 15779055
[TBL] [Abstract] [Full Text] [Related]
[Next]
